Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25498-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MFSD2 antibody
- Antibody type
- Polyclonal
- Description
- MFSD2 antibody (Cat. #25498-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Phosphatidylcholine-derived carriers facilitate brain tumor delivery and enhance glioblastoma therapy.
Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM.
Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM.
Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma.
Yu J, Tu Z, Fan J, Lei K, Meng Z, Chen B, Wang Z, Escobar W, Zhou J
Journal of controlled release : official journal of the Controlled Release Society 2025 Sep 10;385:113999
Journal of controlled release : official journal of the Controlled Release Society 2025 Sep 10;385:113999
Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM.
Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, Sun M, Schmidt A, Clark J, Hawkins W, Mercado N, Real J, Huntington K, Zdioruk M, Nowicki MO, Cho CF, Wu B, Li W, Logan T, Manz KE, Pennell KD, Fedeles BI, Bertone P, Punsoni M, Brodsky AS, Lawler SE
Science advances 2025 Feb 28;11(9):eadr1481
Science advances 2025 Feb 28;11(9):eadr1481
Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM.
Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, Sun M, Schmidt A, Clark J, Hawkins W, Mercado N, Real J, Huntington K, Zdioruk M, Nowicki MO, Cho CF, Wu B, Li W, Logan T, Manz KE, Pennell KD, Fedeles BI, Brodsky AS, Lawler SE
bioRxiv : the preprint server for biology 2024 Aug 28;
bioRxiv : the preprint server for biology 2024 Aug 28;
Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma.
Xie Y, He L, Zhang Y, Huang H, Yang F, Chao M, Cao H, Wang J, Li Y, Zhang L, Xin L, Xiao B, Shi X, Zhang X, Tang J, Uhrbom L, Dimberg A, Wang L, Zhang L
Neuro-oncology 2023 Jun 2;25(6):1073-1084
Neuro-oncology 2023 Jun 2;25(6):1073-1084
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 25498-1-AP( MFSD2 Antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MFSD2 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human MFSD2. This antibody recognizes human antigen. The MFSD2 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
